Skip to main content
. 2016 Aug 17;2(3):192–198. doi: 10.1016/j.trci.2016.07.005

Fig. 1.

Fig. 1

Change in ADAS-Cog14 score* by treatment group (A) and change in ADCS-iADL score* by treatment group (B) from baseline to each visit time point: patients with mild AD dementia (MMSE score, 20–26) at baseline.